title: [Treatment of ischemic myocardiopathy].
abstract: Ischaemic myocardiopathy mandates the control of coronary risk factors and the administration of antiplatelet therapy. If myocardial ischaemia exists, an antianginal treatment will be prescribed. In case of heart failure, the association of an angiotensin-converting enzyme inhibitor and diuretics is required. A beta-blocker, especially at low dose, should be discussed according to the symptoms. When ischaemic cardiomyopathy is asymptomatic, an angiotensin-converting enzyme inhibitors is also likely to benefit the patient. Coronary revascularization may be indicated according to the importance of both residual ischaemia and resistance to medical therapy.
authors.affiliation: Service de cardiologie B, Centre hospitalier universitaire de Nancy-Brabois, Vandoeuvre-les-Nancy.
authors.forename: Y
authors.initials: Y
authors.lastname: Juillière
authors.forename: V
authors.initials: V
authors.lastname: Berder
mesh_terms: D006801:Humans; D017202:Myocardial Ischemia / Q000628:therapy*
vernacular_title: Traitement de la myocardiopathie ischémique.